Chen Yu-Han, Wang Zhi-Bo, Liu Xi-Peng, Xu Jun-Peng, Mao Zhi-Qi
The First Clinical Medical School, Hebei North University, Zhangjiakou, China.
Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing, China.
Front Aging Neurosci. 2024 Jun 5;16:1301854. doi: 10.3389/fnagi.2024.1301854. eCollection 2024.
Depression and Alzheimer's disease (AD) are prevalent neuropsychiatric disorders with intriguing epidemiological overlaps. Their interrelation has recently garnered widespread attention. Empirical evidence indicates that depressive disorders significantly contribute to AD risk, and approximately a quarter of AD patients have comorbid major depressive disorder, which underscores the bidirectional link between AD and depression. A growing body of evidence substantiates pervasive sex differences in both AD and depression: both conditions exhibit a higher incidence among women than among men. However, the available literature on this topic is somewhat fragmented, with no comprehensive review that delineates sex disparities in the depression-AD correlation. In this review, we bridge these gaps by summarizing recent progress in understanding sex-based differences in mechanisms, genetics, and therapeutic prospects for depression and AD. Additionally, we outline key challenges in the field, holding potential for improving treatment precision and efficacy tailored to male and female patients' distinct needs.
抑郁症和阿尔茨海默病(AD)是常见的神经精神疾病,在流行病学上存在有趣的重叠。它们之间的相互关系最近受到了广泛关注。实证证据表明,抑郁症显著增加了患AD的风险,约四分之一的AD患者合并有重度抑郁症,这凸显了AD与抑郁症之间的双向联系。越来越多的证据证实,AD和抑郁症在性别上存在普遍差异:这两种疾病在女性中的发病率均高于男性。然而,关于这一主题的现有文献有些零散,没有全面的综述来描述抑郁症与AD相关性中的性别差异。在本综述中,我们通过总结在理解抑郁症和AD的机制、遗传学及治疗前景方面基于性别的差异的最新进展,填补了这些空白。此外,我们概述了该领域的关键挑战,有望提高针对男性和女性患者不同需求的治疗精准度和疗效。